| References |
1. Momi S, Impagnatiello F, Guzzetta M, Caracchini R, Guglielmini G, Olivieri R, Monopoli A, Gresele P. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Eur J Pharmacol. 2007 Sep 10;570(1-3):115-24. PubMed PMID: 17632098. 2. Rodríguez S, Raurell I, Torres-Arauz M, García-Lezana T, Genescà J, Martell M. A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats. Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461. PubMed PMID: 28084470; PubMed Central PMCID: PMC5233977. 3. Baetta R, Granata A, Miglietta D, Oliva F, Arnaboldi L, Bonomo A, Ferri N, Ongini E, Bellosta S, Corsini A. Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol. Cardiovasc Drugs Ther. 2013 Jun;27(3):211-9. doi: 10.1007/s10557-013-6445-1. PubMed PMID: 23400638. 4. D'Antona G, Mascaro A, Monopoli A, Miglietta D, Ongini E, Bottinelli R. Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice. Muscle Nerve. 2013 Jan;47(1):72-80. doi: 10.1002/mus.23465. PubMed PMID: 23042511. |
